Periodic Reporting for period 1 - SplicEcomplex (Deciphering the structure and dynamics of the early spliceosome assembly)
Reporting period: 2018-04-01 to 2020-03-31
Splicing of pre-mRNA is performed by a large ribonucleoprotein (RNP) complex, the spliceosome, and consists on a precise and coordinated process in which many different components undergo a very dynamic assembly / remodelling / dissociation cycle in which the pre-mRNA recruits the different snRNPs at conserved intron sequences, at different times and in a precise sequence in order to correctly perform the two catalytic steps of splicing. A critical early aspect that directs splicing is the correct spatial disposition of the 5’ and 3’ splice sites in the intron sequence prior to splicing, which is defined as an early step in the cycle with the assembly of spliceosome components in 5' (U1snRNP) and in 3' (SF1-U2AF heterodimer) and their physical connection through bridge proteins (complex E).
Despite of previous structural studies on isolated E complex components and all the exciting and novel cryo-EM structures of several spliceosome catalytic steps that have been obtained in the past few years, there is still lack of information on the whole E complex structural arrangement. Understanding molecular details of E complex and its assembly is essential to reveal mechanisms underlying the regulation of alternative splicing, where in most cases regulatory RBPs, modulate spliceosome assembly at these early steps. Thus, the main goal of this proposal is to obtain high-resolution information on the structure and dynamics of the cross-intron arrangement spliceosome in the E complex stage.
Initial results of this work have been published. Key findings will be published in the near future and have been disseminated in several international conferences and meetings, reaching to a high number of researchers. Results obtained have also been disseminated in several outreach activities highlighting the importance of basic research to the non-academic audience in Europe.